...
首页> 外文期刊>European Journal of Radiology >Long-term follow-up of renal transplant patients with renal artery stenosis treated by percutaneous angioplasty.
【24h】

Long-term follow-up of renal transplant patients with renal artery stenosis treated by percutaneous angioplasty.

机译:经皮血管成形术治疗肾移植狭窄的肾移植患者的长期随访。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE OF THE STUDY: To evaluate if renal angioplasty (PTRA) in patients with transplanted kidney and renal artery stenosis (TRAS) can have long-term effect on hypertension and renal function. MATERIALS AND METHODS: Within a 24-year time period, 58 PTRAs in 55 adults (three times Re-PTRA) with transplanted kidney were performed. The group included 34 males and 21 females, average age 41+/-10.6 (18-72) years. After exclusion of 7 technical failures, 51 PTRAs were followed at 1 week, 6 months and 1-3 years after PTRA. Hypertension improvement was defined as mean arterial pressure (MAP) decrease of at least 15% from the pre-PTRA value. Graft function was evaluated by serum creatinine (Scr) and creatinine clearance (Ccr) levels, and the improvement was defined as a 20% change. Clinical FU was 3 years. RESULTS: PTRA technical success was 88.4%. In 51 kidney recipients at the end of FU, blood pressure improved in 65.2% of patients (MAP decreased from 123+/-13.1 to 107+/-12.1 mmHg), but no patient remained normotensive medication free. Graft function improved in 44.8% of patients and was stabilized in 20.7% of them (average Ccr before PTRA: 0.48+/-0.29, after PTRA: 0.78+/-47 ml/s). PTRA complications were observed in 25.5% of procedures, most often with no clinical sequel. Thirty days mortality was 1.8% (one patient). CONCLUSIONS: PTRA results in kidney recipients are valuable mainly in preserving graft function.
机译:研究目的:评估移植肾和肾动脉狭窄(TRAS)患者的肾血管成形术(PTRA)是否对高血压和肾功能有长期影响。材料与方法:在24年的时间内,对55名成人(移植肾的三倍Re-PTRA)进行了58次PTRA。该组包括34名男性和21名女性,平均年龄41 +/- 10.6(18-72)岁。排除7种技术故障后,在PTRA术后1周,6个月和1-3年随访了51例PTRA。高血压的改善定义为平均动脉压(MAP)比PTRA前降低了至少15%。通过血清肌酐(Scr)和肌酐清除率(Ccr)水平评估移植功能,并将改善定义为20%的变化。临床FU为3年。结果:PTRA技术成功率为88.4%。在FU结束后的51位肾脏接受者中,有65.2%的患者血压有所改善(MAP从123 +/- 13.1 mmHg降至107 +/- 12.1 mmHg),但没有患者保持降压药物治疗。移植功能改善了44.8%,患者稳定了20.7%(PTRA前的平均Ccr:0.48 +/- 0.29,PTRA后的平均Ccr:0.78 +/- 47 ml / s)。在25.5%的手术中观察到PTRA并发症,大多数情况下没有临床后遗症。 30天死亡率为1.8%(一名患者)。结论:肾移植受者的PTRA结果在保留移植物功能方面具有重要价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号